In Brief: Galderma Canada
This article was originally published in The Rose Sheet
Executive Summary
Galderma Canada: Dermatologics company finalizes acquisition of a 13,500 square-meter manufacturing facility in Baie d'Urfe, Quebec, the Mississauga, Ontario-based Galderma subsidiary announced May 6. The new facility will service the U.S., Canada, Mexico, Puerto Rico, Central American and Caribbean markets by distributing the company's dermatological products to wholesalers and pharmacies. Galderma, which is jointly owned by L'Oreal and Nestle, has earmarked about $25.6 mil. ($35 mil. Canadian) to the plant for purchasing, upgrading and installing new equipment based on a May 6 exchange rate of $1 = 1.3652 CDN, the firm said. The company expects the plant to be fully operational by the first quarter of 1998, with the capacity to "produce 40 million units for 70 product forms," the firm said. Galderma manufactures Differin anti-acne treatment and Cetaphil skin cleanser...